Use of MRI in Differentiation of Papillary Renal Cell Carcinoma Subtypes: Qualitative and Quantitative Analysis.
暂无分享,去创建一个
[1] Elliot K Fishman,et al. CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology. , 2014, Academic radiology.
[2] Henry Rusinek,et al. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma. , 2014, AJR. American journal of roentgenology.
[3] I. Pedrosa,et al. MRI Phenotype in Renal Cancer: Is It Clinically Relevant? , 2014, Topics in magnetic resonance imaging : TMRI.
[4] A. Ravaud,et al. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours , 2014, European Radiology.
[5] J. Cheville,et al. The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.
[6] J. Ellis,et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. , 2013, AJR. American journal of roentgenology.
[7] Vicky Goh,et al. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? , 2013, European journal of radiology.
[8] Amish D. Patel,et al. Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma , 2013, European Radiology.
[9] H. Rusinek,et al. Characterization of malignancy of adnexal lesions using ADC entropy: Comparison with mean ADC and qualitative DWI assessment , 2013, Journal of magnetic resonance imaging : JMRI.
[10] Bal Sanghera,et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.
[11] K. Miles,et al. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.
[12] K. Miles,et al. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.
[13] V. Goh,et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.
[14] J. Cheville,et al. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol , 2009, BJU international.
[15] Amnon Zisman,et al. Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma , 2009, Clinical Cancer Research.
[16] Balaji Ganeshan,et al. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. , 2009, Radiology.
[17] M. Remzi,et al. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC , 2008, BJU international.
[18] M. Tsuboi,et al. Differentiation of pathologic subtypes of papillary renal cell carcinoma on CT. , 2008, AJR. American journal of roentgenology.
[19] N. Rofsky,et al. MR classification of renal masses with pathologic correlation , 2008, European Radiology.
[20] C. Elie,et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. , 2007, Urology.
[21] Y. Chrétien,et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. , 2003, The Journal of urology.
[22] B. Delahunt,et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. , 2001, Human pathology.
[23] B. Delahunt,et al. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[24] V. Goh,et al. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.